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We previously reported that the scaffold protein c-Jun NH2-terminal kinase 
(JNK)/stress-activated protein kinase-associated protein 1 (JSAP1) functions in cerebellar 
granule cell precursors (GCPs) to promote their cell-cycle exit and differentiation. In this 
study, we used immunocytochemistry to examine the subcellular distribution of JSAP1 in 
proliferating cultured GCPs. We found that when stimulated with fibroblast growth factor-2 
(FGF-2), a factor that promotes GCP differentiation through JNK and ERK signaling, 
JSAP1 translocated to the plasma membrane and colocalized with activated JNK and 
extracellular signal-regulated kinase (ERK). In transfected cells expressing a constitutively 
activated FGF receptor (FGFR), JSAP1 and the activated FGFR colocalized at the plasma 
membrane with not only activated, but also unphosphorylated and inactive JNK and ERK. 
These colocalizations did not occur when a mutant JSAP1 lacking the JNK-binding domain 
was substituted for wild-type JSAP1. Biochemical analyses of transfected cells showed that 
activated FGFR increased JSAP1’s affinity for JNK and ERK, and that JSAP1 enhanced 
FGFR-induced JNK and ERK activation. Collectively, these results suggest that when 
stimulated by FGFR, JSAP1 translocates to the plasma membrane, where it recruits JNK 




Mammalian mitogen-activated protein kinase (MAPK) intracellular signaling pathways are 
activated in response to a variety of stimuli and play key roles in multiple cellular processes, 
including cell proliferation, differentiation, and apoptosis (Kyriakis and Avruch, 2001; 
Chang and Karin, 2001). The specificity of MAPK signaling is mediated, at least in part, by 
scaffold proteins, which are thought to promote the efficient activation of specific MAPK 
pathways by organizing the signaling components into functional modules (Morrison and 
Davis, 2003; Yoshioka, 2004; Dhanasekaran, et al. 2007). Some extracellular 
signal-regulated kinase (ERK) MAPK signaling scaffolds, such as KSR (kinase suppressor 
of Ras) and MP1 (MEK partner 1), have been shown to coordinate the assembly of 
multiprotein MAPK complexes through subcellular compartmentalization (Müller et al., 
2001; Teis et al., 2002). However, it is largely unknown whether the c-Jun NH2-terminal 
kinase (JNK) MAPK signaling scaffolds possess a similar function. 
The JNK/stress-activated protein kinase-associated protein 1 (JSAP1) [also known as 
JNK-interacting protein 3 (JIP3) or Sunday Driver (Syd)] has been identified as a scaffold 
protein for mammalian JNK signaling modules (Ito et al., 1999, 2000; Kelkar et al., 2000; 
Bowman et al., 2000). Although JSAP1 also seems to be involved in ERK signaling, its role 
in the ERK pathway remains fragmentary (Kuboki et al., 2000; Ha et al., 2005). JSAP1 has 
been reported to assist axonal transport in injured neurons with the aid of the 
dynein/dynactin motor complex (Cavalli et al., 2005). In addition, several scaffold proteins, 
including JSAP1, have been shown to interact with kinesin-1 (Verhey et al., 2001). 
Collectively, these studies suggest that JSAP1 functions dynamically in intracellular 
signaling pathways, and interacts with many different intracellular signaling proteins. To 
date, however, it is not known whether JSAP1 changes its subcellular distribution in 
response to physiological stimuli, or whether JSAP1 regulates MAPK signaling modules in 
a spatial manner. 
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 In rodents, granule cell precursors (GCPs) proliferate extensively for 2-3 weeks after 
birth in the external granular layer, where Purkinje-cell-derived sonic hedgehog (Shh) acts 
as a potent mitogen (Dahmane and Ruiz i Altaba, 1999; Wallace, 1999; Wechsler-Reya and 
Scott, 1999). The proliferating GCPs eventually stop their proliferation, and the postmitotic 
granule cells migrate toward their final destination, the internal granular layer (Hatten, 
1999). We previously reported that JSAP1 antagonizes the mitogenic effect of Shh on GCPs, 
and promotes their exit from the cell cycle and their differentiation, by modulating JNK 
activity (Sato et al., 2008). Fogarty et al. (2007) showed that the fibroblast growth factor-2 
(FGF-2) activity, which is mediated by FGF receptor (FGFR)-JNK/ERK signaling, exerts a 
similar effect on GCPs. In the present study, we found that the subcellular distribution of 
JSAP1 scaffold protein in proliferating cultured GCPs changes in response to the GCP 
differentiation-promoting factor FGF-2, and investigated the role of the JSAP1 
translocation. Our results suggest that when stimulated by FGF-2/FGFR signaling, JSAP1 
regulates the localization of JNK and ERK signaling pathway components, leading to the 





FGF-2 stimulation induces JSAP1 to localize to the plasma membrane in proliferating 
GCPs 
To gain insight into the mechanism by which JSAP1 regulates cellular processes to switch 
from the cell-cycle exit to the differentiation of cerebellar GCPs, we first examined JSAP1’s 
subcellular distribution, focusing on proliferating GCPs. We used cultured GCPs purified 
from the cerebellum of postnatal day 4 (P4) mice. First, we characterized the expression of 
Ki67 (a proliferation marker) and NeuN (a neural differentiation marker) in the primary 
culture system 24 h and 72 h after plating, in the presence or absence of FGF-2 (Fig. 1). In 
the absence of FGF-2, the proportion of Ki67-positive cells decreased over time (41% and 
25% in cells cultured for 24 h and 72 h, respectively), but the percentage of cells expressing 
NeuN increased (51% and 71% in cells cultured for 24 h and 72 h, respectively). Incubation 
with FGF-2 increased GCP differentiation significantly at 24 h (62% NeuN-positive cells) 
and 72 h (87%), and the proportion of Ki67-positive cells observed was lower (31% at 24 h 
and 9% at 72 h). These results are essentially consistent with those reported previously 
(Miyazawa et al., 2000; Fogarty et al., 2007; Sato et al., 2008). 
 We next cultured GCPs with or without FGF-2 for 5 min, 10 min, 20 min, and 30 min,  
double-stained the GCPs with antibodies (Abs) against JSAP1 and Ki67, and used confocal 
microscopy to examine the subcellular distribution of JSAP1 in the Ki67-positive cells (Fig. 
2A,B). In most of the vehicle-treated proliferating GCPs, JSAP1 protein was distributed 
exclusively in the cytoplasm. In contrast, JSAP1 immunosignals were observed at the 
plasma membrane in a significantly increased proportion of the proliferating GCPs treated 
with FGF-2 [41% (5 min), 56% (10 min), 41% (20 min) and 45% (30 min)]. These results 
suggest that JSAP1 translocates to the plasma membrane of Ki67-positive proliferating 
GCPs in response to FGF-2.  
As FGF-2 is known to activate JNK and ERK in GCPs (Fogarty et al., 2007; Fig. S1 in 
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Supporting Information), we then asked whether phosphorylated and activated JNK 
(p-JNK) and ERK (p-ERK) also localize to the plasma membrane in proliferating GCPs, 
and if so, whether p-JNK and/or p-ERK colocalize with the membrane-localized JSAP1 
(Fig. 2C,D). GCPs were cultured with or without FGF-2 for 20 min, triple-stained with Abs 
against JSAP1, Ki67, and p-JNK or p-ERK, and analyzed as described above. While p-JNK 
and p-ERK did not localize to the plasma membrane in vehicle-treated Ki67-positive GCPs, 
among FGF-2-treated GCPs, p-JNK and p-ERK colocalized with JSAP1 at the plasma 
membrane in all of the Ki67-positive GCPs examined. 
We also examined whether JSAP1 protein could be phosphorylated at a tyrosine 
residue when stimulated with FGF-2. To this end, we prepared cell lysates from cultured 
GCPs after treatment with FGF-2 for 0 min, 10 min, 20 min, and 30 min, 
immunoprecipitated the samples with an anti-JSAP1 Ab, and then analyzed the precipitates 
by immunoblotting with an anti-phosphotyrosine-specific Ab (Fig. 3). FGF-2 treatment 
induced the rapid and marked tyrosine phosphorylation of JSAP1, with the highest level 
occurring with the 10-min treatment; the signal was attenuated to a level slightly higher than 
the basal level at 30 min. These results indicated that JSAP1 was phosphorylated on tyrosine 
following stimulation with FGF-2. 
 
JSAP1 colocalizes with myristoylated, activated FGFR1 at the plasma membrane 
We next examined whether the translocation of JSAP1 to the plasma membrane depends on 
FGFR signaling activation. We transiently coexpressed wild-type JSAP1 or a mutant 
lacking the JNK-binding domain [JSAP1(JBD)], along with a constitutively active FGFR1 
in which a myristoylation motif was substituted for the extracellular and transmembrane 
domains of FGFR1 [Myr-FGFR(wt)], thereby targeting the derivative to the plasma 
membrane (Aronheim et al., 1994; Hart et al., 2000). Both HA-tagged wild-type JSAP1 
[HA-JSAP1(wt)] and HA-JSAP1(JBD) colocalized with the Myc-tagged Myr-FGFR(wt) 
[Myr-Myc-FGFR(wt)] at the plasma membrane in all of the transfected human embryonic 
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kidney (HEK) 293T cells examined (Fig. 4). However, when HA-JSAP1(wt) or 
HA-JSAP1(JBD) was coexpressed with a kinase-dead version of Myr-Myc-FGFR(wt) 
[Myr-Myc-FGFR(KD)] in HEK 293T cells, HA-JSAP1 and Myr-Myc-FGFR(KD) did not 
colocalize at the plasma membrane. Taken together, these results suggest that FGFR 
signaling is required for JSAP1 to translocate to the plasma membrane, but that JSAP1’s 
interaction with JNK is not required. 
 We also confirmed that FGFR signaling activation induces the tyrosine 
phosphorylation of JSAP1 in transfected HEK 293T cells, as was observed in cerebellar 
GCPs (Fig. 3). We transiently coexpressed HA-JSAP1(wt) with either Myr-Myc-FGFR(wt) 
or Myr-Myc-FGFR(KD) in HEK 293T cells, immunoprecipitated with an anti-HA Ab, and 
analyzed the precipitates by immunoblotting with an anti-phosphotyrosine-specific Ab (Fig. 
S2 in Supplementary Information). Tyrosine phosphorylation of both HA-JSAP1(wt) and 
HA-JSAP1(JBD) was observed in cells expressing Myr-Myc-FGFR(wt). In contrast, 
when Myr-Myc-FGFR(KD) was used instead of Myr-Myc-FGFR(wt), no tyrosine 
phosphorylation of HA-JSAP1(wt) or HA-JSAP1(JBD) was detected. These results 
indicate that JSAP1 can be phosphorylated on a tyrosine residue, and that the 
phosphorylation is induced by the activation of FGFR signaling.  
 
JSAP1 colocalizes with JNK and ERK at the plasma membrane 
To explore the role of JSAP1’s translocation to the plasma membrane, we transiently 
coexpressed HA-JSAP1(wt or JBD), Myr-Myc-FGFR(wt), and either Flag-tagged 
wild-type JNK [Flag-JNK(wt)] or ERK [Flag-ERK(wt)] in HEK 293T cells, and then 
performed immunocytochemistry with Abs against the HA, Flag, and Myc epitopes. 
HA-JSAP1(wt), Flag-JNK(wt) or Flag-ERK(wt), and Myr-Myc-FGFR(wt) colocalized at 
the plasma membrane in almost all of the transfected cells examined; however, these triple 
colocalizations did not occur when HA-JSAP1(JBD) was expressed instead of 
HA-JSAP1(wt) (Fig. 5A). We also analyzed the transfected cells using a different Ab set, in 
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which we used anti-p-JNK and -p-ERK Abs instead of the anti-Flag Ab, and obtained 
essentially the same results (Fig. S3 in Supporting Information). These results suggested 
that JNK and ERK translocate to the plasma membrane through an interaction with the JBD 
of JSAP1 following FGFR signaling activation. However, it was unclear whether JNK and 
ERK translocate to the plasma membrane before or after being activated. To address this, we 
used mutants of JNK and ERK, in which the Thr and Tyr residues of the TXY motif in their 
activation loops were mutated to Ala and Phe residues, respectively [JNK(APF) and 
ERK(AEF), respectively]. We transiently coexpressed HA-JSAP1(wt or JBD) and 
Myr-Myc-FGFR(wt) with either Flag-JNK(APF) or -ERK(AEF) in HEK 293T cells, and 
analyzed as described above. Again, triple colocalizations of the HA-, Flag- and 
Myc-tagged proteins were observed in almost all of the transfected cells examined when 
HA-JSAP1(wt), but not HA-JSAP1(JBD), was coexpressed with Myr-Myc-FGFR(wt) 
and Flag-JNK(APF) or Flag-ERK(AEF) (Fig. 5B). These results indicate that JNK and 
ERK can translocate to the plasma membrane prior to their activation, through interaction 
with JSAP1. 
 
JSAP1 increases its affinity to JNK and ERK and enhances JNK and ERK activation 
To examine whether FGFR signaling activation affects the interaction of JSAP1 with JNK 
or ERK, we transiently coexpressed either Flag-JNK(wt) or Flag-ERK(wt) with or without 
HA-JSAP1(wt or JBD) and Myr-Myc-FGFR(wt or KD) in HEK 293T cells. Cell lysates 
were immunoprecipitated using an anti-HA Ab, and subjected to immunoblotting with an 
anti-Flag Ab (Fig. 6). The interaction between HA-JSAP1(wt) and Flag-JNK(wt) was 
substantially enhanced by the expression of Myr-Myc-FGFR(wt), but not 
Myr-Myc-FGFR(KD) (Fig. 6A, compare lanes 2 and 3). In addition, when 
HA-JSAP1(JBD) was used instead of HA-JSAP1(wt), no interaction was detected under 
our conditions (Fig. 6A, lanes 6-8). Concerning ERK, an interaction between JSAP1 and 
ERK was observed only in cells coexpressing HA-JSAP1(wt), Myr-Myc-FGFR(wt), and 
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Flag-ERK(wt), but not with other combinations (Fig. 6B).  
  We next examined whether JSAP1 enhanced the FGFR-induced JNK and/or ERK 
activation. We transiently coexpressed either Flag-JNK(wt) (Fig. 7A) or Flag-ERK(wt) (Fig. 
7B) with or without HA-JSAP1(wt or JBD) and Myr-Myc-FGFR(wt or KD) in HEK 293T 
cells, and analyzed by immunoblotting with an anti-phospho-JNK or -ERK Ab after 
immunoprecipitation with an anti-Flag Ab. HA-JSAP1(wt), but not HA-JSAP1(JBD), 
enhanced the activation of Flag-JNK(wt) and -ERK(wt) in cells expressing 
Myr-Myc-FGFR(wt) (Fig. 7A,B, lanes 2-4). The fold increases for JNK and ERK activation 
in the presence of JSAP1, compared to those in its absence, were 1.97 and 2.74, respectively. 
Taken together, these results suggest that when stimulated by FGFR signaling, JSAP1 





We previously reported that JSAP1 signaling pathways regulate cellular programs to switch 
from proliferation to differentiation in cerebellar GCPs (Sato et al., 2008). In the present 
study, we found that the scaffold protein JSAP1 changes its subcellular distribution in 
response to GCP differentiation-promoting signals, and investigated the role of this 
translocation. We propose that when stimulated by FGFRs, JSAP1 translocates to the 
plasma membrane where it recruits JNK and ERK and facilitates their activation, leading to 
the differentiation of cerebellar GCPs. The following lines of evidence support this proposal. 
In cultured cerebellar GCPs, JSAP1 translocates to the plasma membrane and colocalizes 
with activated JNK and ERK when stimulated with FGF-2, a GCP 
differentiation-promoting factor whose activity is mediated by FGFR-JNK/ERK signaling. 
In addition, in transfected cells expressing a constitutively activated FGFR with a 
myristoylation signal, JSAP1 and the activated FGFR colocalize at the plasma membrane 
with not only activated JNK and ERK, but also their unphosphorylated and inactive forms. 
These triple colocalizations do not occur when a mutant JSAP1, JSAP1(JBD), is expressed 
instead of the wild-type JSAP1. Finally, activated FGFR, but not a kinase-dead FGFR, 
increases the affinity of JSAP1 for JNK and ERK, and JSAP1 enhances the FGFR-induced 
JNK and ERK activation. 
 FGFRs, cognate receptors for FGF-2, belong to a receptor tyrosine kinase family. Here 
we examined cerebellar GCPs stimulated with FGF-2, and found that tyrosine 
phosphorylation of JSAP1 was induced rapidly (Fig. 3). It is currently unclear whether 
JSAP1 is directly or indirectly phosphorylated by FGFRs, or whether JSAP1 
phosphorylation affects the JNK and ERK signaling pathways. However, the 
phosphorylation of JSAP1 at tyrosine residue(s) may play a crucial role in the scaffolding 
activity of JSAP1 in FGFR-JNK/ERK signaling pathways, given that an increased affinity 
of JSAP1 for JNK and ERK (Fig. 6), JSAP1 tyrosine phosphorylation (Fig. S2 in 
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Supplementary Information), and JSAP1-enhanced JNK and ERK activation (Fig. 7) were 
all observed in cells expressing activated FGFR, but not in cells expressing a kinase-dead 
FGFR.  
On the other hand, considering the following observations, it is also possible that the 
tyrosine phosphorylation of JSAP1 induced by FGF-2 is important for its translocation to 
the plasma membrane, but not for its scaffolding activity. JSAP1’s phosphorylation in GCPs 
was transient, peaked at 10 min, and returned nearly to baseline by 30 min after FGF-2 
stimulation in GCPs (Fig. 3). In contrast, in proliferating cerebellar GCPs, both the plasma 
membrane localization of JSAP1, and the activation of JNK and ERK by FGF-2 (the latter 
of which has been reported to be crucial for FGF-mediated inhibition of Shh responses; 
Fogarty et al., 2007), were sustained for at least 30 min after stimulation with FGF-2 (Fig. 
2B and Fig. S1 in Supporting Information). JSAP1’s location at the plasma membrane, 
therefore, may be key for the exertion of its scaffolding activity, and the sustained activation 
of JNK and ERK may be required for the differentiation of cerebellar GCPs. Further 
research, including the identification of the phosphorylated tyrosine residue(s) in JSAP1, 
will be necessary to clarify this issue. 
 Here we found that JSAP1 colocalized with activated JNK and ERK at the plasma 
membrane in both FGF-2-stimulated GCPs and transiently transfected cells expressing a 
constitutively activated FGFR (Fig 2B and Fig. S3 in Supporting Information). In addition, 
the colocalization of JSAP1 with unphosphorylated and inactive JNK and ERK, as well as 
with pan-JNK and -ERK, was observed in similar transfection assays (Fig. 5). However, the 
colocalization profiles at the plasma membrane differed between the GCPs and transfected 
cells. In the GCPs, the co-localized proteins seemed to be restricted to certain areas, but in 
the transfected cells, the co-localized proteins were distributed almost uniformly at the 
plasma membrane. It is likely that the overexpressed constitutively activated FGFR in the 
transfected cells was distributed differently from the endogenous FGFRs in the GCPs, 
which resulted in the different distribution profiles of the colocalized proteins. 
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 To date, the role of JSAP1 in ERK signaling remains fragmentary. 
Coimmunoprecipitation studies have shown that JSAP1 interacts selectively with JNK, but 
not ERK, among mammalian MAPKs (Ito et al., 1999; Kelkar et al., 2000). In addition, 
based on the results of cotransfection assays, it has been suggested that JSAP1 inhibits ERK 
pathways by sequestering Raf-1 and MEK (MAPK and ERK kinase) from ERK signaling 
modules (Kuboki et al., 2000). On the other hand, biochemical studies of Jsap1-deficient 
mice have suggested a positive role of JSAP1 in ERK signaling (Ha et al., 2005). Here we 
found that JSAP1 can bind ERK in cells expressing activated FGFR (Fig. 6B), and that 
JSAP1 enhances the ERK activation induced by activated FGFR (Fig. 7B). In our 
previously reported cotransfection assays (Kuboki et al., 2000), JSAP1 was unable to exert 
scaffolding activity, probably because it was unable to bind ERK under the experimental 
conditions; conversely, JSAP1 might acquire a scaffolding role in ERK modules if it gains 
the capacity to interact with ERK. Indeed, we observed that JSAP1 interacted with ERK in 
cells expressing activated FGFR, but not in cells expressing a kinase-dead FGFR (Fig. 6B). 
Thus, it seems likely that JSAP1 assembles ERK signaling components into functional 
modules following FGFR activation. 
 In summary, this study shows for the first time that the scaffold protein JSAP1 
regulates the localization of components in the JNK and ERK signaling pathways. Our 
findings suggest that when stimulated by FGFRs, JSAP1 can convert unscaffolded kinases 
to scaffolded kinases through its translocation to the cell plasma membrane, and promote 
activation of the relevant signaling cascades. Furthermore, this study implies that JSAP1 
functions as a scaffolding factor to modulate the parallel but distinct JNK and ERK 






All of the experiments involving animals were conducted according to the Fundamental 
Guidelines for Proper Conduct of Animal Experiments and Related Activities in Academic 
Research Institutions under the jurisdiction of the Ministry of Education, Culture, Sports, 
Science and Technology of Japan. C57BL/6J mice were purchased from SLC (Hamamatsu, 
Japan). 
 
Cell cultures and transfection 
HEK 293T cells were cultured as described previously (Bayarsaikhan et al., 2007). 
Transient transfection into HEK 293T cells was performed using FuGene6 (Roche, Basel, 
Switzerland), according to the manufacturer’s instructions. Cerebellar GCPs were prepared 
from P4 mice, purified, and cultured as described previously (Sato et al., 2008). The purified 
GCPs were plated onto eight-well Lab-Tec chamber slides (8 x 105 cells/well; Permanox 
slide; Nunc Inc., Naperville, IL, USA) coated with 50 µg/ml poly-L-lysine (Sigma, St. 
Louis, MO, USA). For some experiments, FGF-2 (25 ng/ml; Sigma) dissolved in 
phosphate-buffered saline (PBS) was added to the culture medium 1 h after plating. 
 
Plasmids 
The mammalian expression plasmids, pCL20c CMV-HA-JSAP1(wt), pCL20c 
CMV-HA-JSAP1(JBD), and pFlag-CMV2-JNK3(wt) were described previously (Ito et al., 
1999; Sato et al., 2008). To generate the expression plasmid for Flag-tagged wild-type ERK, 
the entire coding region of mouse ERK2 (RefSeq accession no. NM_011949) was amplified 
by polymerase chain reaction (PCR). The product, which contained a NotI site at the 5’ end 
and a stop codon followed by a BamHI site at the 3’ end of the sense strand, was digested 
with NotI and BamHI, and subcloned into NotI/BamHI-digested pFlag-CMV2 (Codak, 
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Rochester, NY, USA) to generate pFlag-CMV2-ERK2(wt). Expression plasmids for 
Flag-tagged kinase-dead JNK3 and ERK2, pFlag-CMV2-JNK3(APF) and -ERK2(AEF), 
were constructed by replacing Thr183 and Tyr185 (both JNK3 and ERK2) with alanine and 
phenylalanine, respectively. To introduce the nucleotide substitutions into the cDNAs, 
site-directed mutagenesis was carried out by overlapping PCR as described previously (Ito 
et al., 1999) using the following primers: Jnk3, sense strand, 
5’-ACAAGCTTCATGATGGCTCCGTTCGTGGTGACGCGATAT-3’; Erk2, sense strand, 
5’-CACACAGGGTTCTTGGCAGAGTTCGTAGCCACACGTTGG-3’. The underlined 
letters represent the mutated nucleotides. Annealed oligonucleotides encoding the 
myristoylation signal of c-Src (GSSKSKPKDPSQR, one-letter code for amino acids) were 





’. Annealed oligonucleotides encoding the Myc epitope (EQKLISEEDL, one-letter code for 
amino acids) were inserted into the EcoRV site of pcDNA3-Myr to generate 
pcDNA3-Myr-Myc: forward, 5’-GAGCAGAAGCTGATCAGCGAGGAGGACCTGGAT 
T-3’; reverse, 5’-ATCCAGGTCCTCCTCGCTGATCAGCTTCTGCTC-3’. The region 
encoding amino acid residues 398-822 of mouse FGFR1 (RefSeq accession no. 
NM_010206) was amplified by PCR. The product, which contains an EcoRV site at the 5’ 
end and a stop codon followed by an SalI site at the 3’ end of the sense strand, was digested 
with EcoRV and SalI, and subcloned into EcoRV/XhoI-digested pcDNA3-Myr-Myc to 
generate pcDNA3-Myr-Myc-FGFR1(wt). The expression plasmid for a kinase-dead version 
of Myr-Myc-FGFR(wt), pcDNA3-Myr-Myc-FGFR1(KD), was constructed by replacing 
Lys514 with arginine. The corresponding nucleotide substitutions were introduced by 
overlapping PCR using the following primers: Fgfr1, sense strand, 5’- 
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GACCAAAGTGGCCGTGAGAATGTTGAAGTCCGACG-3’. The underlined letters 
represent the mutated nucleotides. 
 Nucleotide sequences of the expression plasmids were confirmed by DNA sequencing. 
 
Immunocytochemistry 
HEK 293T cells were plated onto plastic cover slips (Sumitomo Bakelite, Tokyo, Japan) in 
24-well plates at a density of 1 x 104 cells per well. The cells were transfected with 20 ng 
pcDNA3-Myr-Myc-FGFR(wt or KD) and 40 ng pCL20c CMV-HA-JSAP1(wt or JBD) 
with or without 40 ng of either pFlag-CMV2-JNK3(wt or APF) or pFlag-CMV2-ERK2(wt 
or AEF), as indicated in the figures. pCMV (Clontech, Palo Alto, CA, USA) was used to 
normalize the total quantity of transfected DNA (200 ng/transfection). Twenty-four hours 
after the transfection of HEK 293T cells or after the treatment of cultured cerebellar GCPs 
with FGF-2 or vehicle (i.e., PBS) for the times indicated in the figures and/or figure legends, 
cells were fixed with 4% paraformaldehyde in Tris-buffered saline (TBS) pH 7.4 for 30 min 
at room temperature. Fluorescence immunocytochemistry was performed by standard 
protocols using blocking solution (2% BSA, 2% goat serum, 0.4% Triton X-100 in TBS), 
primary Abs, and secondary Abs.  
Primary Abs were as follows: rat monoclonal anti-Ki67 (1:100; Dako, Glostrup, Denmark), 
mouse monoclonal anti-NeuN (1:300; Chemicon, Temecula, CA, USA), rabbit polyclonal 
anti-JSAP1 (1 µg/ml; Miura et al., 2006), mouse monoclonal anti-phospho-JNK and 
anti-phospho-ERK (both diluted to 1:100; Santa Cruz Biotechnology, Santa Cruz, CA, 
USA), mouse monoclonal anti-Flag M2 and rabbit polyclonal anti-Myc (both diluted to 
1:1000; Sigma), and rat polyclonal anti-HA (1:1000; Roche) Abs. Secondary Abs were goat 
Alexa fluor 488-conjugated anti-rat or rabbit IgG, goat Alexa fluor 568-conjugated 
anti-mouse or rat IgG, and goat Alexa fluor 647-conjugated anti-rat or rabbit IgG Abs (each 
diluted to 1:1000; Invitrogen). Nuclei were stained with 2 µg/ml Hoechst 33258 
(Invitrogen).  
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 Images were captured with a confocal laser-scanning microscope (LSM510; Zeiss, 
Oberkochem, Germany). 
 
Immunoblotting and immunoprecipitation 
HEK 293T cells were plated in 35-mm dishes at a density of 2 x 105 cells per dish. The cells 
were transfected with various combinations of pcDNA3-Myr-Myc-FGFR(wt or KD), 
pCL20c CMV-HA-JSAP1(wt or JBD), pFlag-CMV2-JNK3(wt or APF), and 
pFlag-CMV2-ERK2(wt or AEF) as indicated in the figures, in which the amount of these 
vectors used for each transfection was 100 ng, 200 ng, 200 ng, and 200 ng, respectively. 
pCMV (Clontech) was used to normalize the total quantity of transfected DNA (1,000 
ng/transfection). Twenty-four hours after the transfection of HEK 293T cells or after the 
treatment of cultured cerebellar GCPs with FGF-2 for the times indicated in the figures, 
cells were lysed in RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Nonidet P40, 
0.1% sodium deoxycholate) containing 25 mM -glycerophosphate, 1 mM sodium 
orthovanadate, 1 mM sodium fluoride, and Protease Inhibitor Cocktail (Sigma). 
Immunoblotting was carried out as described previously (Sato et al., 2004), using mouse 
monoclonal anti-phospho-tyrosine (1:1000; Millipore, Bedford, MA, USA), mouse 
monoclonal horseradish peroxidase (HRP)-conjugated anti-Flag M2 and rabbit polyclonal 
anti-Myc (both diluted 1:5000; Sigma), rat polyclonal anti-HA (1:5000; Roche), rabbit 
polyclonal anti-JSAP1 (0.33 µg/ml; Miura et al., 2006), rabbit polyclonal anti-JNK, 
anti-ERK, anti-phospho-JNK and anti-phospho-ERK (each diluted 1:1000; Cell Signaling 
Technology, Beverly, MA, USA) Abs. Secondary Abs were sheep anti-mouse, donkey 
anti-rabbit (both from GE Healthcare, Buckinghamshire, UK), and goat anti-rat (Santa 
Cruz) HRP-conjugated IgG Abs (each diluted 1:5000). Protein bands were visualized by the 
Immobilon Western Chemiluminescence system (Millipore), and were quantified using 
ImageJ software. 
 To examine protein phosphorylation, cell lysates prepared using RIPA buffer were 
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immunoprecipitated with rabbit polyclonal anti-JSAP1 (1 µg/ml; Miura et al., 2006), rat 
polyclonal anti-HA (1:500; Roche), or mouse monoclonal anti-Flag M2 (1:1000; Sigma) 
Abs bound to protein G-Sepharose beads (GE Healthcare), and then subjected to 
immunoblotting. To analyze protein-protein interactions, transfected HEK 293T cells were 
lysed in Lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 2 mM EDTA, 10% Glycerol, 
1% Triton X-100) containing 25 mM -glycerophosphate, 1 mM sodium orthovanadate, 1 
mM sodium fluoride, and Protease Inhibitor Cocktail. The cell lysates were 
immunoprecipitated with rat polyclonal anti-HA (1:500; Roche) Ab bound to protein 
G-Sepharose beads, and subjected to immunoblotting. 
 
Statistical analysis 
Results are represented as the mean + SEM from the number of experiments indicated in the 
figure legends. Statistical differences were analyzed using the two-tailed unpaired Student’s 
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Figure 1. Expression of Ki67 and NeuN in cultured cerebellar GCPs. GCPs prepared from 
P4 mice were cultured with vehicle or FGF-2 for 24 h or 72 h, fixed, and stained with Abs 
against Ki67 and NeuN. Percentages of Ki67 and NeuN-expressing cells are shown (means 
+ SEM from 3 experiments, *, P < 0.01, Student’s t-test). Over 500 cells were counted per 
experiment.  
 
Figure 2. JSAP1 translocates to the plasma membrane in cultured proliferating cerebellar 
GCPs in response to FGF-2. (A) P4 GCPs were treated with vehicle or FGF-2 for 10 min. 
The cells were double-stained with Abs to JSAP1 (green) and Ki67 (red) as indicated, and 
used in confocal analysis. Bright-field images are also shown. FGF-2 induces JSAP1 to 
translocate from the cytoplasm to the plasma membrane in Ki67-positive GCPs. (B) GCPs 
were treated with vehicle or FGF-2 for the indicated times, and analyzed as in (A). 
Percentages of plasma membrane-localized JSAP1 in Ki67-positive GCPs are shown 
(means + SEM from 3 experiments, *, P < 0.001, Student’s t-test). Over 100 cells were 
examined in each experiment. (C, D) GCPs were treated with vehicle or FGF-2 for 20 min. 
The cells were triple-stained with Abs to JSAP1, Ki67, and p-JNK (C) or p-ERK (D) as 
indicated, and used in confocal analysis. FGF-2 induces p-JNK and p-ERK to localize at the 
plasma membrane in Ki67-positive GCPs, where they colocalize with JSAP1 in all the cells 
examined. A minimum of 50 cells was examined in each experiment. Scale bars, 5 µm in A, 
C and D. 
 
Figure 3. Tyrosine phosphorylation of JSAP1 in cultured cerebellar GCPs when stimulated 
with FGF-2. P4 GCPs were treated with FGF-2 for the indicated times. The cells were lysed, 
immunoprecipitated (IP) using anti-JSAP1 Ab, and analyzed by immunoblotting (IB) with 
anti-p-Tyr Ab. Aliquots of the immunoprecipitates were also analyzed by IB, using 
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anti-JSAP1 Ab as a control for immunoprecipitation efficiency. JSAP1 expression in total 
cell lysates is shown (input, bottom panel). The results shown are representative of three 
independent experiments. 
 
Figure 4. JSAP1 colocalizes with myristoylated, activated FGFR at the plasma membrane 
in HEK 293T cells. HEK 293T cells were transiently cotransfected with expression vectors 
for HA-JSAP1(wt or JBD) and Myr-Myc-FGFR(wt or KD) as indicated. The cells were 
double-stained with anti-Myc (green) and anti-HA (red) Abs, and used in confocal analysis. 
Both HA-JSAP1(wt) and HA-JSAP1(JBD) colocalize with Myr-Myc-FGFR(wt), but not 
with Myr-Myc-FGFR(KD), at the plasma membrane in all the transfected cells examined. A 
minimum of 100 cells was examined in each experiment. Scale bars, 10 µm. 
 
Figure 5. JSAP1 colocalizes with JNK and ERK at the plasma membrane in HEK 293T 
cells expressing activated FGFR. HEK 293T cells were transiently cotransfected with 
expression vectors for HA-JSAP1(wt or JBD) and Myr-Myc-FGFR(wt), along with either 
Flag-JNK(wt) or Flag-ERK(wt) (A), or Flag-JNK(APF) or Flag-ERK(AEF) (B), as 
indicated. The cells were triple-stained with anti-HA (green), anti-Flag (red) and anti-Myc 
(blue) Abs, and used in confocal studies. HA-JSAP1(wt)  and Myr-Myc-FGFR(wt) 
colocalizes with not only Flag-JNK(wt) and Flag-ERK(wt) (A), but also their mutants 
Flag-JNK(APF) and Flag-ERK(AEF) (B) at the plasma membrane in almost all the 
transfected cells examined. These triple colocalizations were absent in cells expressing 
HA-JSAP1(JBD) instead of HA-JSAP1(wt). Over 100 cells were examined in each 
experiment. Scale bars, 10 µm. 
 
Figure 6. Activated FGFR enhances the affinity of JSAP1 to JNK and ERK in HEK 293T 
cells. HEK 293T cells were transiently cotransfected with expression vectors for 
HA-JSAP1(wt or JBD) and Myr-Myc-FGFR(wt or KD), along with either Flag-JNK(wt) 
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(A) or Flag-ERK(wt) (B) as indicated. The cells were lysed, immunoprecipitated (IP) using 
anti-HA Ab, and analyzed by immunoblotting (IB) with anti-Flag Ab. Aliquots of the 
immunoprecipitates were also analyzed by IB, using anti-HA Ab as a control for 
immunoprecipitation efficiency. The expression of HA-JSAP1(wt or JBD) and  
Myr-Myc-FGFR(wt or KD) along with either Flag-JNK(wt) (A) or Flag-ERK(wt) (B) in 
total cell lysates is shown (input, bottom three panels in A and B). The results shown are 
representative of three independent experiments. 
 
Figure 7. JSAP1 enhances FGFR-induced JNK and ERK activation. HEK 293T cells were 
transiently cotransfected with expression vectors for HA-JSAP1(wt or JBD) and 
Myr-Myc-FGFR(wt or KD), with either Flag-JNK(wt) (A) or Flag-ERK(wt) (B), as 
indicated. The cells were lysed, immunoprecipitated (IP) using anti-Flag Ab, and analyzed 
by immunoblotting (IB) with anti-p-JNK (A) or anti-p-ERK (B) Abs. Aliquots of the 
immunoprecipitates were also analyzed by IB with anti-Flag Ab as a control for 
immunoprecipitation efficiency. The expression of HA-JSAP1(wt or JBD),  
Myr-Myc-FGFR(wt or KD) and Flag-JNK(wt) (A) or Flag-ERK(wt) (B) in total cell lysates 
is shown (input, bottom three panels in A and B). The results shown are representative of 





Figure S1. FGF-2 activates JNK and ERK in cultured cerebellar GCPs. P4 GCPs were 
treated with FGF-2 for the indicated times. The cells were lysed and analyzed by 
immunoblotting (IB) with Ab against p-JNK, JNK, p-ERK and ERK as indicated. The 
results shown are representative of three independent experiments. 
 
Figure S2. JSAP1 tyrosine phosphorylation in HEK 293T cells expressing activated FGFR. 
HEK 293T cells were transiently cotransfected with expression vectors for HA-JSAP1(wt 
or JBD) and Myr-Myc-FGFR(wt or KD), as indicated. The cells were lysed, 
immunoprecipitated (IP) using anti-HA Ab, and analyzed by immunoblotting (IB) with 
anti-p-Tyr Ab. Aliquots of the immunoprecipitates were also analyzed by IB, using anti-HA 
Ab as a control for immunoprecipitation efficiency. HA-JSAP1 and Myr-Myc-FGFR 
expression in total cell lysates is shown (input, bottom two panels). The results shown are 
representative of three independent experiments. 
 
Figure S3. JSAP1 colocalizes with p-JNK and p-ERK at the plasma membrane in HEK 
293T cells expressing the activated FGFR. HEK 293T cells were transiently cotransfected 
with expression vectors for HA-JSAP1(wt or JBD) and Myr-Myc-FGFR(wt) together with 
Flag-JNK(wt) (A) or Flag-ERK(wt) (B), as indicated. The cells were triple-stained with 
anti-HA (green), anti-Myc (blue) and anti-pJNK or anti-p-ERK (red) Abs, and used in 
confocal studies. HA-JSAP1(wt) and Myr-Myc-FGFR(wt) colocalizes with p-JNK and 
p-ERK at the plasma membrane in all the transfected cells examined. This triple 
colocalization does not occur in cells expressing HA-JSAP1(JBD) instead of 
HA-JSAP1(wt). Over 100 cells were examined in each experiment. Scale bars, 10 µm. 










